In 2023, prescription drug spending grew 13.6% compared with 2022 and semaglutide was the highest selling drug due to a recent increase of weight-loss classifications. Despite Americans' mixed opinions on newly approved drugs for weight-loss, researchers predict an even further increase of spending for these drugs in 2024. | image credit: K KStock / stock.adobe.comThe Rise of Weight-Loss Drug Spending in the USWhether patients are using these drugs for weight-loss or diabetes management, in 2023, Novo Nordisk saw combined sales of $21.1 billion from its drugs Wegovy, Ozempic, and Rybelsus. Enormous demand for weight-loss drugs drives up total U.S. prescription spending. DeSilver D. As obesity rates rise in the U.S. and worldwide, new weight-loss drugs surge in popularity.

Source: Washington Post May 02, 2024 18:20 UTC